logo

Moleculin Biotech Inc (MBRX)



Trade MBRX now with
  Date
  Headline
10/13/2020 7:32:19 AM Moleculin Announces Additional Positive Interim Results In Adult Glioblastoma Clinical Trial
10/6/2020 7:35:30 AM Moleculin Biotech Announces New Findings In Vitro Activity Against HIV
10/5/2020 7:36:01 AM Moleculin Biotech Appoints Elizabeth Cermak To Board
10/1/2020 7:41:44 AM Moleculin Announces Positive Interim Results In Pediatric Brain Tumor Phase 1 Trial At Emory University
9/29/2020 7:59:41 AM Moleculin Announces Discovery Of Significant In Vitro Activity Against COVID-19 Virus For New Antimetabolites
9/14/2020 7:39:19 AM Moleculin Biotech To Test Antiviral Activity Of WP1122 In COVID-19 Animal Model
9/9/2020 7:35:40 AM Moleculin Biotech Intends To File IND Using Annamycin For Soft Tissue Sarcomas With Lung Metastases By Year-End
8/12/2020 7:44:19 AM Moleculin Biotech Q2 Net Loss $10.1 Mln Vs. Net Loss Of $1.2 Mln Prior Year
7/21/2020 7:36:08 AM Moleculin Biotech Says New Independent Laboratory Testing Confirms Antiviral Activity Of WP1122 Against Coronavirus
7/15/2020 7:34:24 AM Moleculin Biotech Enters Deal With Sterling Pharma USA LLC For US Production Of WP1122
7/2/2020 7:35:38 AM Moleculin Biotech Announces Update On Clinical Development Plan For Annamycin
6/25/2020 7:34:04 AM Moleculin Announces Preclinical Data Confirms Efficacy Of Annamycin In Lung Metastases